Latest ERBB Stories
-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.
HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis
Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer.
Metastasis is the spread of breast cancer due to an original tumor; this process is the leading cause of death for women with breast cancer, but now there’s hope.
- Large; stout; burly.